Percodan and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Percodan (aspirin; oxycodone hydrochloride; oxycodone terephthalate), especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years also take Synthroid, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Weakness when taking Percodan. It is created by eHealthMe based on reports of 12,849 people who have side effects when taking Percodan from the FDA, and is updated regularly.

What is Percodan?

Percodan has active ingredients of aspirin; oxycodone hydrochloride; oxycodone terephthalate. It is often used in pain. eHealthMe is studying from 12,885 Percodan users. Check the latest studies of Percodan.

What is Weakness?

Weakness is found to be associated with 3,635 drugs and 6,562 conditions by eHealthMe. Check the latest studies of Weakness.

On Dec, 21, 2025

12,849 people reported to have side effects when taking Percodan.
Among them, 37 people (0.29%) have Weakness.

Among these 37 people:

How long have people been on Percodan when they have Weakness? *

What is the gender of people who have Weakness when taking Percodan? *

female: 45.95 %
male: 54.05 %

What is the age of people who have Weakness when taking Percodan? *

What are other drugs people take besides Percodan? *

What are other side effects people have besides Weakness? *

Chest Pain: 21 people, 56.76%
Headache (pain in head): 20 people, 54.05%
Fatigue (feeling of tiredness): 17 people, 45.95%
Weight Decreased: 17 people, 45.95%
Depression: 15 people, 40.54%
Stress And Anxiety: 15 people, 40.54%
Fever: 15 people, 40.54%
Dyspnea (difficult or laboured breathing): 14 people, 37.84%
Pneumonia: 14 people, 37.84%
Swallowing Difficulty: 14 people, 37.84%

What are the existing conditions these people have? *

Neuralgia (pain in one or more nerves): 6 people, 16.22%
High Blood Cholesterol: 6 people, 16.22%
Hyperthyroidism (over activity of the thyroid gland): 5 people, 13.51%
Depression: 4 people, 10.81%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.70%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 2.70%
Enlarged Prostate: 1 person, 2.70%
Breast Cancer: 1 person, 2.70%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.70%
Acute Myocardial Infarction (acute heart attack): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Percodan and have Weakness?

- Check whether Weakness is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Percodan:

Percodan (12,885 reports)

Weakness treatments and more:

Weakness (586,863 reports)

How severe was Weakness and when was it recovered:

Weakness in Percodan

Expand to all the drugs that have ingredients of aspirin; oxycodone hydrochloride; oxycodone terephthalate:

Weakness and drugs with ingredients of aspirin; oxycodone hydrochloride; oxycodone terephthalate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Percodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,635 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,562 conditions)

Drugs similar to Percodan and Weakness :

How the study uses the data?

The study uses data from the FDA. It is based on aspirin; oxycodone hydrochloride; oxycodone terephthalate (the active ingredients of Percodan) and Percodan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.